BAT Releases 2024 Fiscal Year Trading Update on December 11th

Dec.11.2024
BAT Releases 2024 Fiscal Year Trading Update on December 11th
BAT announces strong growth in new product categories and traditional tobacco revenues for the second half of 2024 fiscal year.

On December 11, British American Tobacco (BAT) released a trading update for the fiscal year ending 2024. The company stated that the accelerated growth in the second half of 2024 was in line with expectations, primarily driven by innovation in new product categories. Revenue from new product categories and traditional tobacco is expected to increase in the second half of the year compared to the first half.


BAT expects that by the end of 2024, the cash conversion rate will exceed 90%, while the leverage ratio will be within the target range of 2.0-2.5 times. Additionally, they have expressed support for the Canadian Companies' Creditors Arrangement Act (CCAA) and are hopeful to reach a conclusion that is beneficial for all stakeholders.


In the traditional tobacco industry, the United States' business actions continued to gain momentum in the second half of the year; in the AME and APMEA regions, its market share continued to grow. Investments in the first half of the year in the US business actions and wholesale inventory adjustments drove an increase in organic sales volume and financial performance in the traditional tobacco business in the second half of the year. Despite a slight decrease in value share due to the impact of the US market's geographic mix, volume share increased by 20 basis points in key markets.


The performance of new business categories is also improving. Vuse e-cigarettes maintain a leading market share globally, with a 40.3% share in key markets (50.7% share in tracked channels in the U.S.). Meanwhile, the innovative product line of the glo brand is showing signs of accelerated growth in the second half of the year, with new products like glo Hyper Pro driving sales growth. The Velo brand continues to experience strong growth in markets outside the U.S., solidifying its position as a leader in the oral market.


BAT expects a decrease in sales of approximately 2% in 2024, with organic revenue and profit growth forecasted to be in the low single digits. Planned capital expenditure is around 600 million pounds, and net financial expenses are expected to be 1.6 billion pounds, impacted by fluctuations in exchange rates and interest rates.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Intensifies Tobacco Crime Crackdown, Strengthens Cross-Border Cooperation
China Intensifies Tobacco Crime Crackdown, Strengthens Cross-Border Cooperation
In the first half of 2025, China intensified efforts to combat tobacco-related offenses. According to official media under the State Tobacco Monopoly Administration (STMA), authorities handled 186,000 administrative tobacco cases nationwide, marking a 35.9% year-on-year increase. Among them, 10,710 were major cases involving over 50,000 yuan in value—a 160.3% surge from the same period last year.
Aug.19
New Russian Law Comes Into Effect: Unlabeled Nicotine Products in Circulation Could Face Up to Three Years in Prison
New Russian Law Comes Into Effect: Unlabeled Nicotine Products in Circulation Could Face Up to Three Years in Prison
From August 3, 2025, Russia's new law penalizes unlabeled nicotine products, including e-liquids. Offenders may face fines up to 500,000 rubles ($5,000), forced labor, or up to three years in prison with an extra 120,000 rubles ($1,200) fine. Violations over 100,000 rubles ($1,000) are large-scale, over 1,000,000 rubles ($10,000) are especially large-scale.
Aug.04 by 2FIRSTS.ai
Pelham, USA to Suspend New CBD and Vape Shop Licenses Until End of 2026
Pelham, USA to Suspend New CBD and Vape Shop Licenses Until End of 2026
The Pelham City Council in the U.S. unanimously passed a temporary ban on establishing new CBD and vape shops until December 31, 2026. This move allows the city time to adapt to Alabama’s new cannabis-derived product regulations (House Bill 445), effective January 1, 2026. The ban does not affect existing businesses but prevents new stores from opening.
Jul.23 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
Imperial Brands Urges UK Government to Strengthen E-Cigarette Sales Guidelines and Promote Refillable Devices
Imperial Brands Urges UK Government to Strengthen E-Cigarette Sales Guidelines and Promote Refillable Devices
Imperial Brands urges the UK to strengthen e-cigarette sales guidance, supporting pod-only sales compatible with reusable devices. The company says this approach, alongside the disposable vape ban, can better reduce e-waste and improve cost-effectiveness.
Jul.30 by 2FIRSTS.ai
Massachusetts Proposes Ban on Tobacco Sales to Anyone Born After 2006, Sparking Debate
Massachusetts Proposes Ban on Tobacco Sales to Anyone Born After 2006, Sparking Debate
Massachusetts lawmakers are weighing a bill to create a “nicotine-free generation” by banning tobacco sales to anyone born on or after January 1, 2006. While some cities have adopted similar measures, critics argue it restricts personal freedom and hurts local businesses. Supporters say the law would protect future generations from targeting by Big Tobacco.
Jul.17 by 2FIRSTS.ai